| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |